[Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients]
【聚乙二醇干扰素α-2b注射液（Y型，40 kD）治疗HBeAg阳性慢性乙型肝炎患者的临床疗效及安全性】
期刊:Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
影响因子:
doi:10.3760/cma.j.issn.1007-3418.2017.08.007
Hou, F Q; Yin, Y L; Zeng, L Y; Shang, J; Gong, G Z; Pan, C; Zhang, M X; Yin, C B; Xie, Q; Peng, Y Z; Chen, S J; Mao, Q; Chen, Y P; Mao, Q G; Zhang, D Z; Han, T; Wang, M R; Zhao, W; Liu, J J; Han, Y; Zhao, L F; Luo, G H; Zhang, J M; Peng, J; Tan, D M; Li, Z W; Tang, H; Wang, H; Zhang, Y X; Li, J; Zhang, L L; Chen, L; Jia, J D; Chen, C W; Zhen, Z; Li, B S; Niu, J Q; Meng, Q H; Yuan, H; Sun, Y T; Li, S C; Sheng, J F; Cheng, J; Sun, L; Wang, G Q
